Regardless of whether you have diabetes, a medical professional can diagnose low B12 quickly and accurately with just a CBC and B12 blood test level
Consistency is the most important factor
If the off-label use of GLP-1s for type 1 diabetes becomes so prevalent as to be impossible to ignore, the FDA might mandate the companies to go and do these studies, says Garg
A key challenge in studying native GLP-1 is its extremely short in vivo half-life of approximately 12 minutes, owing to rapid inactivation by dipeptidyl peptidase-4 (DPP-4), which cleaves the N-terminal His-Ala dipeptide from GLP-1 to produce the inactive metabolite GLP-1(936)amide
"And number two, from a dermatologist's perspective, it's worrisome what it does to moles and the potential for melanoma." Dr Goodman says Melanotan II can change the appearance and shape of moles, making melanoma harder to detect